RS49691B - Liofilizovan preparat ljudskog morfogenetskog faktora mp52 kosti - Google Patents

Liofilizovan preparat ljudskog morfogenetskog faktora mp52 kosti

Info

Publication number
RS49691B
RS49691B YUP-349/99A YU34999A RS49691B RS 49691 B RS49691 B RS 49691B YU 34999 A YU34999 A YU 34999A RS 49691 B RS49691 B RS 49691B
Authority
RS
Serbia
Prior art keywords
bone morphogenetic
morphogenetic factor
lyophilized composition
factor human
human
Prior art date
Application number
YUP-349/99A
Other languages
English (en)
Inventor
Hideki Ichikawa
Mitsuko Inagaki
Original Assignee
Biopharm Gesellschaft Zur Biotechnologischen Entwicklung Von Pharmaka Mbh.,
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biopharm Gesellschaft Zur Biotechnologischen Entwicklung Von Pharmaka Mbh., filed Critical Biopharm Gesellschaft Zur Biotechnologischen Entwicklung Von Pharmaka Mbh.,
Publication of YU34999A publication Critical patent/YU34999A/sh
Publication of RS49691B publication Critical patent/RS49691B/sr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1875—Bone morphogenic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Liofilizovan preparat humanog koštanog morfogenetskog faktora MP52 i, naznačen time, što sadrži smešu humanog morfogenetskog faktora MP52 i manitola u težinskom odnosu 1:5-50. Prijava sadrži još 1 nezavisan i 2 zavisna patentna zahteva.
YUP-349/99A 1997-01-30 1998-01-29 Liofilizovan preparat ljudskog morfogenetskog faktora mp52 kosti RS49691B (sr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1634997 1997-01-30

Publications (2)

Publication Number Publication Date
YU34999A YU34999A (sh) 2002-08-12
RS49691B true RS49691B (sr) 2007-12-31

Family

ID=11913900

Family Applications (1)

Application Number Title Priority Date Filing Date
YUP-349/99A RS49691B (sr) 1997-01-30 1998-01-29 Liofilizovan preparat ljudskog morfogenetskog faktora mp52 kosti

Country Status (22)

Country Link
EP (1) EP0972520B9 (sr)
JP (1) JP4209948B2 (sr)
KR (1) KR100548107B1 (sr)
CN (1) CN1152712C (sr)
AP (1) AP983A (sr)
AT (1) ATE302021T1 (sr)
AU (1) AU737595B2 (sr)
BR (1) BR9807537B1 (sr)
CA (1) CA2278546C (sr)
DE (1) DE69831223T9 (sr)
DK (1) DK0972520T3 (sr)
EA (1) EA001579B1 (sr)
ES (1) ES2244043T3 (sr)
HU (1) HU226554B1 (sr)
IL (2) IL130967A0 (sr)
NO (1) NO322334B1 (sr)
NZ (1) NZ336509A (sr)
PL (1) PL189381B1 (sr)
RS (1) RS49691B (sr)
SI (1) SI0972520T1 (sr)
TR (1) TR199901832T2 (sr)
WO (1) WO1998033514A1 (sr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69814352T3 (de) † 1997-02-07 2009-08-13 Stryker Corp., Kalamazoo Matrixlose osteogene vorrichtungen und implantate und verfahren zu deren verwendung
EP1434569A1 (en) * 2001-10-09 2004-07-07 CellFactors plc Therapeutic biological product and method for formation of new vascularised bone
BR0214275A (pt) 2001-11-19 2004-09-21 Scil Technology Gmbh Dispositivo tendo propriedades osteocondutora e osteoindutora
ES2260685T3 (es) 2002-09-10 2006-11-01 Scil Technology Gmbh Implante metalico recubierto, a una concentracion de oxigeno reducida, con proteina osteoinductora.
US20060204511A1 (en) * 2003-08-05 2006-09-14 Bouwstra Jan B Use of recombinant or synthetic gelatin as stabiliser in vaccines
JP2007534633A (ja) * 2003-11-10 2007-11-29 アライバ−プロメティック インコーポレイティド ヒト・アルファ１−抗トリプシン製剤
ES2350939T3 (es) 2004-03-10 2011-01-28 Scil Technology Gmbh Implantes recubiertos, su fabricación y uso de los mismos.
US10216709B2 (en) 2015-05-22 2019-02-26 Microsoft Technology Licensing, Llc Unified messaging platform and interface for providing inline replies
US20160344677A1 (en) 2015-05-22 2016-11-24 Microsoft Technology Licensing, Llc Unified messaging platform for providing interactive semantic objects

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0080879B1 (en) * 1981-11-28 1986-10-01 Sunstar Kabushiki Kaisha Pharmaceutical composition containing interferon in stable state
US5037644A (en) * 1986-10-27 1991-08-06 Cetus Corporation Pharmaceutical compositions of recombinant interleukin-2 and formulation processes
AU663328B2 (en) * 1991-06-21 1995-10-05 Genetics Institute, Llc Pharmaceutical formulations of osteogenic proteins
JP2966592B2 (ja) * 1991-07-20 1999-10-25 萩原 義秀 安定化されたヒトモノクローナル抗体製剤
WO1993016099A2 (en) * 1992-02-12 1993-08-19 Biopharm Gesellschaft Zur Biotechnologischen Entwicklung Von Pharmaka Mbh Dna sequences encoding novel growth/differentiation factors
CA2093836A1 (en) * 1992-04-24 1993-10-25 Wayne Gombotz Biodegradable tgf-.beta. delivery system for bone regeneration
DE4239877C1 (de) * 1992-11-27 1994-03-17 Boehringer Ingelheim Int Stabilisierte Superoxid-Dismutase (SOD)-Zusammensetzung
WO1996029095A1 (en) * 1995-03-21 1996-09-26 Applied Research Systems Ars Holding N.V. Hcg liquid formulations
DE69636728D1 (de) * 1995-04-19 2007-01-04 Bioph Biotech Entw Pharm Gmbh Neues protein und verfahren zu dessen herstellung

Also Published As

Publication number Publication date
DE69831223T2 (de) 2006-02-16
AP9901602A0 (en) 1999-09-30
IL130967A0 (en) 2001-01-28
HUP0002386A2 (hu) 2000-11-28
AU5679198A (en) 1998-08-25
HU226554B1 (en) 2009-03-30
NO993702L (no) 1999-09-29
KR20000070586A (ko) 2000-11-25
PL334852A1 (en) 2000-03-27
EP0972520A1 (en) 2000-01-19
SI0972520T1 (sl) 2006-02-28
EA199900694A1 (ru) 2000-04-24
JP4209948B2 (ja) 2009-01-14
KR100548107B1 (ko) 2006-02-02
NO322334B1 (no) 2006-09-18
NO993702D0 (no) 1999-07-29
NZ336509A (en) 2001-03-30
AP983A (en) 2001-07-16
PL189381B1 (pl) 2005-07-29
IL130967A (en) 2006-12-10
ATE302021T1 (de) 2005-09-15
DE69831223D1 (de) 2005-09-22
ES2244043T3 (es) 2005-12-01
BR9807537A (pt) 2000-03-21
WO1998033514A1 (fr) 1998-08-06
EA001579B1 (ru) 2001-06-25
CN1244127A (zh) 2000-02-09
DK0972520T3 (da) 2005-12-19
TR199901832T2 (xx) 1999-12-21
YU34999A (sh) 2002-08-12
AU737595B2 (en) 2001-08-23
CA2278546C (en) 2008-04-01
EP0972520B9 (en) 2006-03-22
EP0972520A4 (en) 2002-11-05
EP0972520B1 (en) 2005-08-17
DE69831223T9 (de) 2006-12-07
BR9807537B1 (pt) 2009-01-13
HUP0002386A3 (en) 2002-09-30
CA2278546A1 (en) 1998-08-06
CN1152712C (zh) 2004-06-09

Similar Documents

Publication Publication Date Title
EP0950665A4 (en) PHYSIOLOGICALLY ACTIVE MODIFIED PROTEINS AND DRUG COMPOSITIONS CONTAINING THEM
ID23807A (id) Metoda dan komposisi yang mengandung-semen untuk digunakan dalam bawah tanah
ID24520A (id) Analog-analog peptida lh-rh, penggunaannya dan komposisi farmasi yamg mengandungnya
FI952119A0 (fi) Stabiili pakastekuivattu koostumus, joka sisältää proteiinia ja testipakkaus
BG101132A (en) Pyridoanilated thienyl and furanyl oxazolidinons
HK1015269A1 (en) Use of r-enantiomer of n-propargyl-1-aminoindan, salts, and compositions thereof
HUP0100101A3 (en) Prostaglandin agonists, pharmaceutical compositions comprising thereof and their use
CA2281562A1 (en) Forskolin for promoting lean body mass
SI1019358T2 (sl) 3,3-diarilpropilamini, njihova uporaba in priprava
IL127366A0 (en) Insulin preparations containing NaCl
HK1030939A1 (en) Aroyl-piperazine derivatives, their preparation and their use as tachykinin antagonists
IL133997A (en) 2-[pyrazolyl- and triazolyl-3'-oxymethylene] phenylisoxazolones, -triazolones and -tetrazolones, their preparation and compositions comprising them
DE69830119D1 (de) Teigzusammensetzung und derer Herstellung
EE200000226A (et) 3,6-poolketaalid 9a-asaliidide klassist, nende valmistamismeetod ja farmatseutiline kompositsioon
HUP9902586A3 (en) Mixtures derived from grains of eugenia jambolana lamarck, preparation and use of said mixtures and some of their constituents as medicaments
HUP9801256A3 (en) 5'-deoxy-cytidine derivatives, preparation and use thereof and pharmaceutical compositions
RS49691B (sr) Liofilizovan preparat ljudskog morfogenetskog faktora mp52 kosti
HUT71377A (en) Artificial tanning cosmetical compositions based on dihydroxyacetone, preparation and use of them
DE69634489D1 (de) Adenovirus dodekahedrischer proteinkomplex, dieser enthaltende zusammensetzung und verwendungen davon
EP0915826A4 (en) SPASMOLYTIC AGENT FOR SMOOTH MUSCLE, COMPOSITIONS AND METHODS OF USE RELATING TO THIS AGENT
ID23156A (id) Turunan-turunan amidina, proses pembuatan komposisi dan penggunaannya
BG101849A (en) Bicyclic tachyquinine antagonists, their preparation and use in pharmaceutical compositions
EE200000207A (et) 8-asabitsüklo[3.2.1]oktaan-3-metaanamiini derivaadid, nende valmistamine ja terapeutiline kasutamine
ATE196914T1 (de) Lh-rh analoge mit starrer konformation, deren verwendungen und pharmazeutische zusammensetzungen
HUP9903098A3 (en) Combination comprising vx478, zidovudine and/or 1592u89 and pharmaceutical composition containing them